Metlife Inc (MET) concluded trading on Thursday at a closing price of $83.05, with 3.02 million shares of worth about $251.01 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 3.23% during that period and on March 27, 2025 the price saw a loss of about -1.05%. Currently the company’s common shares owned by public are about 689.21M shares, out of which, 566.91M shares are available for trading.
Stock saw a price change of 0.40% in past 5 days and over the past one month there was a price change of 0.62%. Year-to-date (YTD), MET shares are showing a performance of 1.43% which increased to 13.61% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $67.30 but also hit the highest price of $89.05 during that period. The average intraday trading volume for Metlife Inc shares is 3.43 million. The stock is currently trading 1.11% above its 20-day simple moving average (SMA20), while that difference is down -0.50% for SMA50 and it goes to 4.34% higher than SMA200.
Metlife Inc (NYSE: MET) currently have 689.21M outstanding shares and institutions hold larger chunk of about 75.52% of that.
The stock has a current market capitalization of $56.58B and its 3Y-monthly beta is at 0.86. PE ratio of stock for trailing 12 months is 13.93, while it has posted earnings per share of $5.96 in the same period. Its PEG reads 1.12 while making debt-to-equity ratio of 0.70. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for MET, volatility over the week remained 1.72% while standing at 2.41% over the month.
Stock’s fiscal year EPS is expected to rise by 15.02% while it is estimated to increase by 11.72% in next year. EPS is likely to grow at an annualized rate of 12.43% for next 5-years, compared to annual growth of -0.38% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by BMO Capital Markets on January 23, 2025 offering a Market perform rating for the stock and assigned a target price of $97 to it. Coverage by TD Cowen stated Metlife Inc (MET) stock as a Buy in their note to investors on October 09, 2024, suggesting a price target of $97 for the stock. On September 05, 2024, Barclays Initiated their recommendations, while on January 08, 2024, Goldman Upgrade their ratings for the stock with a price target of $80. Stock get an Overweight rating from Barclays on November 17, 2023.
